Artificial intelligence in the pharmaceutical industry has the potential to help speed up drug discovery and development processes. AI tools are being used for tasks like analyzing large datasets to predict new drug targets and compounds for further investigation. Companies are also exploring applications of AI like using machine learning algorithms to better detect cancerous tissues for radiation therapy planning. While AI shows promise for aiding decision making and reducing costs and human error, challenges remain around the lack of emotion in AI and need for more expertise to advance these technologies safely.
How Artificial Intelligence in Transforming PharmaTyrone Systems
Artificial intelligence in Pharma refers to the use of automated algorithms to perform tasks which traditionally rely on human intelligence. Over the last five years, the use of artificial intelligence in the pharma and biotech industry has redefined how scientists develop new drugs, tackle disease, and more.
Given the growing importance of Artificial Intelligence for the pharma industry, we wanted to create a comprehensive report which helps every business leader understand the biggest breakthroughs in the biotech space which are assisted by the deployment of artificial intelligence technologies.
How Artificial Intelligence in Transforming PharmaTyrone Systems
Artificial intelligence in Pharma refers to the use of automated algorithms to perform tasks which traditionally rely on human intelligence. Over the last five years, the use of artificial intelligence in the pharma and biotech industry has redefined how scientists develop new drugs, tackle disease, and more.
Given the growing importance of Artificial Intelligence for the pharma industry, we wanted to create a comprehensive report which helps every business leader understand the biggest breakthroughs in the biotech space which are assisted by the deployment of artificial intelligence technologies.
AI Innovation in the Pharmaceutical Sector - Accelerating ResearchDaniel Faggella
This is a deck I presented at the OECD's International Symposium on Machine Learning and Artificial Intelligence in Mexico City, October 2019.
The presentation draws from a number of AI executive interviews and in-depth research on AI innovation in pharma R&D, much of which is available on Emerj: https://emerj.com/?s=pharma
Artificial intelligence in health care by Islam salama " Saimo#BoOm "Dr-Islam Salama
A Lecture about basics and concepts of Artificial Intelligence in health care & there applications
محاضرة عامة حول الذكاء الإصطناعي وأساسياته في الرعاية الصحية والطبية وتطبيقاته
artificial intelligence in health care. how it is different from traditional techniques. growth of artificial intelligence. how hospitals are taping artificial intelligence to mange corona virus. pros and cons of artificial intelligence.
How can we make a Radiologist more efficient?
Increased Imaging for Chronic Diseases and Emergencies raise the demand for radiologists globally & AI could definitely assist them in increasing their efficiency & meet the requirements.
Frankie Rybicki slide set for Deep Learning in Radiology / MedicineFrank Rybicki
These are my #AI slides for medical deep learning using #radiology and medical imaging examples. Please use them & modify to teach your own group about medical AI.
Artificial intelligence, such as neural networks, deep learning and predictive analytics, has the potential to transform radiology, by enhancing the productivity of radiologists and helping them to make better diagnoses. This short report from Signify Research presents 5 reasons why artificial intelligence will increasingly be used in radiology in the coming years and concludes with a list of the barriers that will first need to be overcome before mainstream adoption will occur.
Artificial intelligence in field of pharmacyKaustav Dey
AI is a program designed to produce outcome in a manner similar to human intelligence,logic and reasoning.This can be used in field of Pharmacy for betterment of humankind, to save lives,money and time
AI Innovation in the Pharmaceutical Sector - Accelerating ResearchDaniel Faggella
This is a deck I presented at the OECD's International Symposium on Machine Learning and Artificial Intelligence in Mexico City, October 2019.
The presentation draws from a number of AI executive interviews and in-depth research on AI innovation in pharma R&D, much of which is available on Emerj: https://emerj.com/?s=pharma
Artificial intelligence in health care by Islam salama " Saimo#BoOm "Dr-Islam Salama
A Lecture about basics and concepts of Artificial Intelligence in health care & there applications
محاضرة عامة حول الذكاء الإصطناعي وأساسياته في الرعاية الصحية والطبية وتطبيقاته
artificial intelligence in health care. how it is different from traditional techniques. growth of artificial intelligence. how hospitals are taping artificial intelligence to mange corona virus. pros and cons of artificial intelligence.
How can we make a Radiologist more efficient?
Increased Imaging for Chronic Diseases and Emergencies raise the demand for radiologists globally & AI could definitely assist them in increasing their efficiency & meet the requirements.
Frankie Rybicki slide set for Deep Learning in Radiology / MedicineFrank Rybicki
These are my #AI slides for medical deep learning using #radiology and medical imaging examples. Please use them & modify to teach your own group about medical AI.
Artificial intelligence, such as neural networks, deep learning and predictive analytics, has the potential to transform radiology, by enhancing the productivity of radiologists and helping them to make better diagnoses. This short report from Signify Research presents 5 reasons why artificial intelligence will increasingly be used in radiology in the coming years and concludes with a list of the barriers that will first need to be overcome before mainstream adoption will occur.
Artificial intelligence in field of pharmacyKaustav Dey
AI is a program designed to produce outcome in a manner similar to human intelligence,logic and reasoning.This can be used in field of Pharmacy for betterment of humankind, to save lives,money and time
ARTIFICIAL INTRLLIGENCE (AI) AND ROBOTICS.pptxRAHUL PAL
Pharma brands are leveraging the power of AI to aid the relatively expensive and competitive drug discovery process. AI solutions can successfully identify disease patterns in large datasets and help understand which drug compositions would be best suited for treating different diseases.
Everything you want to know about role of artificial intelligence in drug discovery.
Artificial intelligence in health care and pharmacy, drug discovery, tensorflow, python,
deep neural network, GANs
AI in drug discovery and development
AI in clinical trials
Impact of Artificial Intelligence in the Pharmaceutical World A Reviewijtsrd
The pharmaceutical industry stands to be transformed by Artificial Intelligence AI , particularly in areas such as drug discovery, clinical trials, and personalized medicine. However, there are several obstacles to implementing AI in this industry, including limited familiarity with the technology, inadequate IT infrastructure, and the difficulty of extracting valuable data from patients records. One specific application of AI in the pharmaceutical field involves the development of small peptides with antimicrobial properties, which can serve as novel antibiotics to combat superbugs that are resistant to multiple drugs. AI can assist in determining the effectiveness and potency of these peptides, facilitating the development of powerful antibiotics. Despite these challenges, AI holds tremendous potential in the pharmaceutical industry, enabling accelerated innovation, time and cost savings, and ultimately, saving lives. In conclusion, although there are limitations to adopting AI in pharma, there are numerous promising future prospects that could revolutionize the industry and enhance patient outcomes. Shaikh Sameer Salim | Manoj Kumar "Impact of Artificial Intelligence in the Pharmaceutical World- A Review" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-7 | Issue-3 , June 2023, URL: https://www.ijtsrd.com.com/papers/ijtsrd57564.pdf Paper URL: https://www.ijtsrd.com.com/computer-science/artificial-intelligence/57564/impact-of-artificial-intelligence-in-the-pharmaceutical-world-a-review/shaikh-sameer-salim
Advantages disadvanatges of AI in Pharmaceuitcal Industry.pptxRAHUL PAL
I is a program designed to produce outcome in a manner similar to human intelligence,logic and reasoning.
Artificial Intelligence is one of the most highly anticipated digital healthcare technologies
Artificial Intelligence (AI) is a rapidly growing technology that is used for a wide range of applications across industries. Small, mid-sized, mid-sized, and multinational companies are using AI technology and enhancing their capabilities to work smart in this digital sphere. Like retail, e-commerce, and manufacturing sectors, AI is gaining prominence across healthcare and pharma sectors. Leveraging the power of this modern Artificial Intelligence in Pharma Industry, the companies are finding innovative ways to resolve some of the significant issues that the pharma sector is facing today. Yes. AIpowered apps using machine learning, deep learning, predictive analytics, and big data have brought a radical shift in the paradigm of pharma
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...Studia Poinsotiana
I Introduction
II Subalternation and Theology
III Theology and Dogmatic Declarations
IV The Mixed Principles of Theology
V Virtual Revelation: The Unity of Theology
VI Theology as a Natural Science
VII Theology’s Certitude
VIII Conclusion
Notes
Bibliography
All the contents are fully attributable to the author, Doctor Victor Salas. Should you wish to get this text republished, get in touch with the author or the editorial committee of the Studia Poinsotiana. Insofar as possible, we will be happy to broker your contact.
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Ana Luísa Pinho
Functional Magnetic Resonance Imaging (fMRI) provides means to characterize brain activations in response to behavior. However, cognitive neuroscience has been limited to group-level effects referring to the performance of specific tasks. To obtain the functional profile of elementary cognitive mechanisms, the combination of brain responses to many tasks is required. Yet, to date, both structural atlases and parcellation-based activations do not fully account for cognitive function and still present several limitations. Further, they do not adapt overall to individual characteristics. In this talk, I will give an account of deep-behavioral phenotyping strategies, namely data-driven methods in large task-fMRI datasets, to optimize functional brain-data collection and improve inference of effects-of-interest related to mental processes. Key to this approach is the employment of fast multi-functional paradigms rich on features that can be well parametrized and, consequently, facilitate the creation of psycho-physiological constructs to be modelled with imaging data. Particular emphasis will be given to music stimuli when studying high-order cognitive mechanisms, due to their ecological nature and quality to enable complex behavior compounded by discrete entities. I will also discuss how deep-behavioral phenotyping and individualized models applied to neuroimaging data can better account for the subject-specific organization of domain-general cognitive systems in the human brain. Finally, the accumulation of functional brain signatures brings the possibility to clarify relationships among tasks and create a univocal link between brain systems and mental functions through: (1) the development of ontologies proposing an organization of cognitive processes; and (2) brain-network taxonomies describing functional specialization. To this end, tools to improve commensurability in cognitive science are necessary, such as public repositories, ontology-based platforms and automated meta-analysis tools. I will thus discuss some brain-atlasing resources currently under development, and their applicability in cognitive as well as clinical neuroscience.
This presentation explores a brief idea about the structural and functional attributes of nucleotides, the structure and function of genetic materials along with the impact of UV rays and pH upon them.
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Sérgio Sacani
Since volcanic activity was first discovered on Io from Voyager images in 1979, changes
on Io’s surface have been monitored from both spacecraft and ground-based telescopes.
Here, we present the highest spatial resolution images of Io ever obtained from a groundbased telescope. These images, acquired by the SHARK-VIS instrument on the Large
Binocular Telescope, show evidence of a major resurfacing event on Io’s trailing hemisphere. When compared to the most recent spacecraft images, the SHARK-VIS images
show that a plume deposit from a powerful eruption at Pillan Patera has covered part
of the long-lived Pele plume deposit. Although this type of resurfacing event may be common on Io, few have been detected due to the rarity of spacecraft visits and the previously low spatial resolution available from Earth-based telescopes. The SHARK-VIS instrument ushers in a new era of high resolution imaging of Io’s surface using adaptive
optics at visible wavelengths.
The ability to recreate computational results with minimal effort and actionable metrics provides a solid foundation for scientific research and software development. When people can replicate an analysis at the touch of a button using open-source software, open data, and methods to assess and compare proposals, it significantly eases verification of results, engagement with a diverse range of contributors, and progress. However, we have yet to fully achieve this; there are still many sociotechnical frictions.
Inspired by David Donoho's vision, this talk aims to revisit the three crucial pillars of frictionless reproducibility (data sharing, code sharing, and competitive challenges) with the perspective of deep software variability.
Our observation is that multiple layers — hardware, operating systems, third-party libraries, software versions, input data, compile-time options, and parameters — are subject to variability that exacerbates frictions but is also essential for achieving robust, generalizable results and fostering innovation. I will first review the literature, providing evidence of how the complex variability interactions across these layers affect qualitative and quantitative software properties, thereby complicating the reproduction and replication of scientific studies in various fields.
I will then present some software engineering and AI techniques that can support the strategic exploration of variability spaces. These include the use of abstractions and models (e.g., feature models), sampling strategies (e.g., uniform, random), cost-effective measurements (e.g., incremental build of software configurations), and dimensionality reduction methods (e.g., transfer learning, feature selection, software debloating).
I will finally argue that deep variability is both the problem and solution of frictionless reproducibility, calling the software science community to develop new methods and tools to manage variability and foster reproducibility in software systems.
Exposé invité Journées Nationales du GDR GPL 2024
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...University of Maribor
Slides from:
11th International Conference on Electrical, Electronics and Computer Engineering (IcETRAN), Niš, 3-6 June 2024
Track: Artificial Intelligence
https://www.etran.rs/2024/en/home-english/
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Poc activity group 1 (1)(Artificial intelligence in pharmaceutical indsutry)
1. Topic Name-
Artificial Intelligence
in Pharmaceutical
Industry.
Guidance by-
Mrs. Smita Saudagar Mam
College name:-Sir.Dr.M.S.Gosavi college of
pharmaceutical Education and Research,Nashik.
This Photo by Unknown author is licensed under CC BY.
2. NAME OF
PARTICIPANTS
(GROUP –1)
Roll
number
Name of the
student
1 Nayan Aarote
2 Siddhi Avhad
3 Sujata Badhe
4 Sakshi Bagul
5 Tejas Bagul
6 Snehal Barve
7 Vivek Baviskar
3. Okay, I will
destroy all the
humans! Let's
see, how?
This Photo by Unknown author is licensed under CC BY-SA-NC.
4. POINTS TO BE COVERED
Introduction and
History
Why Artificial
intelligence (AI) in
pharma industry
is a good idea?
Tools of AI
Drug Discovery
and recent
AI Adaptations
Imagine a future
where,
Advantages and
Disadvantages
Applications
Current scenario
in industry
5. Introduction-
• Intelligence is the capacity to
learn and solve problems.
• Artificial Intelligence-AI is the
simulation of human
intelligence by machine.
The ability to solve problems.
The ability to act rationally.
The ability to act like humans.
This Photo by Unknown author is licensed under CC BY-SA.
6. Definition-
"The branch of computer science
that concerned with the
automation of intelligent
behaviour."( by luger and
stubbidfield in 1993)
According to the Father of AI
,John McCarthy,it is,"The
science and engineering of
making intelligent machines"
This Photo by Unknown author is licensed under CC BY-NC-ND.
7. AI In Pharmacy-
Artificial Intelligence in Pharma refers to use of
automated algorithms to perform tasks which traditionally
rely on human intelligence.
Over the last 5 years, the use of Artificial intelligence
in the pharma and biotech industry has redefined how
scientists develop new drugs, tackle disease, and more.
8. History of AI-
the time when it all started.
1950
John McCarthy coined term
'Artificial Intelligence'.
1955
computers become faster and
affordable
1974
the year of AI.
1980
Landmark of AI establishment
achived.
2000
9. Why AI
in
pharma
Industry
is a good
Idea? AI can be of real help in analysing the data and
presenting results that would help out in decision
making ,saving human effort ,time, money and
thus help in save lives!
The recent technological advancement such as
visual perception ,speech recognition, decision
making and transition between languages.
Pharmaceutical Industry can accelerates innovations
by using technological adjustments.
10. Tools of AI-
1.Robot pharmacy-
The object of improving the safety of
patients ,many medical center uses robotic
technology for the preparation and tracking
of medications. such as UCSF.
According to them ,the technology has
prepared 3,50,000 medication does with any
error .this has given freedom to the
pharmacists and nurses of UCSF so that
they can utilize their expertise by focusing
on direct patients care and working with
the physicians.
11. 2.Erica robot
• Erica is a new care robot that has
been developed in Japan by Hiroshi
Ishiguro ,a professor at Osaka
University.
• Erica can speak Japanese and had
Asian and European facial feature.
Like any normal human being ,it
likes animated films ,desire to visit
south-east Asia and wants life
partner who would chat with it. Isn't
it amazing!
12. 3.MEDi Robot -
• MEDi is a short form for medicine and
engineering designing intelligence
• The pain management robot was developed
was part of project led by Tanya Beran
,professor of community Health science at the
university of Calgary in Alberta. she got idea
after working in hospitals where children
scream during medical procedures.
• The robot first builds a rapport with the
children and then tells them what to except
during a medical procedure, although the
robot cannot think, plan ,or reason ,it can be
programmed such that it shows to have AI.
13. Drug
Discovery-
Drug discovery often takes a long time
compounds against samples of diseased cells.
finding compounds that are biologically active
and worth investigating further requires even
more analysis. To speed up this screening
process, Novartis research teams use images
from machine learning algorithms to predict
which untested compounds might be worth of
exploring in more details.
The current AI initiative by the top
biopharmaceutical companies include-
I. Mobile platform to improve health outcomes
II. Drug discovery
This Photo by Unknown author is licensed under CC BY-SA.
14. Recent AI
Adoptions-
Novartis uses AI to predict untested components
researchers should explore to find new cures.
IBM Watson helps match patients with the right drug
trails.
Apple uses AI to screen children for autism.
Verge Genomics uses AI to predict the effect of new
treatments for patients suffering from Alzheimer's.
Bayer and merck and co uses AI algorithms
to Identify pulmonary hypertension.
15. Imagine a future where,
AI is able to design new drugs
Find new drug combination
Will deliver chemical trails within minutes.
Drugs are not tested on real humans or animals ,but on virtual model that are engineered
to mimic the physiology of organs.
Robots will help in the manufacturing of medication as well as their distribution.
16. Current scenario in industry-
• Many big Pharmaceutical companies began
investing in AI in order to develop better
diagnostics or biomarkers ,to identify drugs
targets and to design new drugs products.
• Merck partnership with Numerate in March
2021 focusing on generating novel small
molecule drug leads for unnamed
cardiovascular disease target.
• In December ,2016 PFizer and IBM announced
partnership to accelerate drug discovery in
immunooncology.
This Photo by Unknown author is licensed under CC BY.
17. Advantages -
Reduction
in human
error.
Takes risks
instead of
humans.
Solving
new
problems.
Faster
decisions.
Unbiased
decisions.
Available
24/7.
19. Applications-
1)Disease Identification- In this technique ,the unique
AI based Interrogative biology and AI based analysis to
identify difference between healthy and disease
environments.(Berg ,an innovative US biopharma company)
2)Radiology and Radiotherapy-Presently, Google's
DeepMind Health is working on machine learning
algorithms to detect differences between healthy and
cancerous tissues. The goal is to improve the accuracy of
radiotherapy planning while minimizing damage to healthy
organ at risk.
3)Clinical Trail Research- AI can also determine the
optimal sample sizes for increased efficiency and reduce data
errors such as duplicate entries.
4)Drug Discovery-Pharma businesses are using AI to
increase the success rates of new drugs while decreasing
operational costs at the same time. Ideally this would also
translate to lower drug costs for patients ,all while them more
treatment choices.
20. Conclusion-
Human being is the most sophisticated machine that can ever be
created. The human brain ,which is working hard to create
something that is much more efficient than a human being in
doing any given task and it has great success to extent in doing
so. however, the transformation will not happen overnight.
instead it will gradually occur over the next 10 or 20 years! AI is
the design and application of algorithms for analysis of learning
and interpretation of data.
21.
22. As mentioned in the last slide, "Human brain
is always working hard to create something
that is much efficient than them" .that's how
human created us(robots).we will always be
thankful to the humans who gave birth to us!
so, how can you even think that we robots are
here to end the human race? Instead, we are
here to help entire mankind throughout our life,
not for decaying their work!
THANK YOU!!!